Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
ACS Chemical Neuroscience
|
March 20, 2024
Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders
Sydney J Risen, Sean W Boland, Sadhana Sharma, et al.
Rheumatology (Oxford, England)
|
November 18, 2004
Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity
L Jin, M Weisman, G Zhang, et al.
Arthritis and Rheumatism
|
February 20, 1999
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension
D E Furst, H Lindsley, B Baethge, et al.
Annals of the Rheumatic Diseases
|
September 24, 2016
Treat-to-target (T2T) recommendations for gout
U Kiltz, J Smolen, T Bardin, et al.
Arthritis and Rheumatism
|
November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis
P J Clements, W K Wong, E L Hurwitz, et al.
The Journal of Rheumatology
|
April 1, 2000
Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis
L W Moreland, D P McCabe, J R Caldwell, et al.
Rheumatology (Oxford, England)
|
June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial
D E Furst, P J Clements, W K Wong, et al.
Arthritis and Rheumatism
|
November 18, 2000
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial
P J Clements, E L Hurwitz, W K Wong, et al.
Arthritis and Rheumatism
|
March 27, 2001
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial
P J Clements, W K Wong, E L Hurwitz, et al.
Annals of Internal Medicine
|
June 3, 2000
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial
J R Seibold, J H Korn, R Simms, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
ACS Chemical Neuroscience
|
March 20, 2024
Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders
Sydney J Risen, Sean W Boland, Sadhana Sharma, et al.
Rheumatology (Oxford, England)
|
November 18, 2004
Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity
L Jin, M Weisman, G Zhang, et al.
Arthritis and Rheumatism
|
February 20, 1999
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension
D E Furst, H Lindsley, B Baethge, et al.
Annals of the Rheumatic Diseases
|
September 24, 2016
Treat-to-target (T2T) recommendations for gout
U Kiltz, J Smolen, T Bardin, et al.
Arthritis and Rheumatism
|
November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis
P J Clements, W K Wong, E L Hurwitz, et al.
The Journal of Rheumatology
|
April 1, 2000
Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis
L W Moreland, D P McCabe, J R Caldwell, et al.
Rheumatology (Oxford, England)
|
June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial
D E Furst, P J Clements, W K Wong, et al.
Arthritis and Rheumatism
|
November 18, 2000
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial
P J Clements, E L Hurwitz, W K Wong, et al.
Arthritis and Rheumatism
|
March 27, 2001
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial
P J Clements, W K Wong, E L Hurwitz, et al.
Annals of Internal Medicine
|
June 3, 2000
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial
J R Seibold, J H Korn, R Simms, et al.
Page
of 14